Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study
Version 2 2024-04-25, 07:37Version 2 2024-04-25, 07:37
Version 1 2024-03-27, 15:14Version 1 2024-03-27, 15:14
media
posted on 2024-04-25, 07:37authored byAdis Journals on behalf of:, Andres Yarur, Gerassimos J. Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler
The above Graphical Abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).